Structure Info
- Chemspace ID
- CSSS00159262905 (In-Stock Screening Compounds)
- MFCD
- MFCD00198062
- IUPAC Name
- (2S,3R,4S,5S,6R)-6-({[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl (4aS,6aS,6bR,8aR,9R,10S,12aR,12bR,14bS)-10-{[(2S,3R,4S,5S)-4,5-dihydroxy-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate
- Mol formula
- C59H96O26
- Mol weight
- 1221 Da
- Catalog Number(s)
- 25138, 27013-76-9, 44242, 44242-0.25G, 464601, A351772, AA007YWS, AGN-PC-0PRXGA, AP14216036, ArZ-UP480492, B0005-464601, BBC14216036, BBP04054, BD132971, CD11260273, CFN90183, CSC159262905, D659786, H129970, HY-N0253, LN01345241, M17289, NP7027, OH32563, S3919, SC-72867, T3370, Y0101, ZX-CY002268
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- -1.31
- Heavy atoms count
- 85
- Rotatable bond count
- 14
- Number of rings
- 10
- Carbon bond saturation, Fsp3
- 0.949
- Polar surface area (Å)
- 413
- Hydrogen bond acceptors count
- 25
- Hydrogen bond donors count
- 15
- Zoom the structure
- CSSS00159262905
Items Overall 9 items from 3 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
MedChemExpress | 10 days | United States To: | 99 | 25 mg | 60 | |
MedChemExpress | 10 days | United States To: | 99 | 50 mg | 110 | |
MedChemExpress | 10 days | United States To: | 99 | 100 mg | 200 | |
MedChemExpress | 10 days | United States To: | 99 | 10mM/1mL | 66 | |
Description: Names: Hederacoside C; Kalopanaxsaponin B; Product Description: Hederacoside C (Kalopanaxsaponin B) is an ingredient that can be obtained mainly from ivy leaves. Hederacoside C mediates inflammation by inhibiting activation of MAPK/NF-κB and its downstream signaling pathway. Hederacoside C has anti-inflammatory and antibacterial activity .; Target: Apoptosis;Bacterial;NF-κB;p38 MAPK; CAS: 14216-03-6 | ||||||
MedChemExpress EU | 10 days | Sweden To: | 99 | 25 mg | 63 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 50 mg | 116 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 100 mg | 211 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10mM/1mL | 69 | |
Description: Names: Hederacoside C; Kalopanaxsaponin B; Product Description: Hederacoside C (Kalopanaxsaponin B) is an ingredient that can be obtained mainly from ivy leaves. Hederacoside C mediates inflammation by inhibiting activation of MAPK/NF-κB and its downstream signaling pathway. Hederacoside C has anti-inflammatory and antibacterial activity; Target: Apoptosis;Bacterial;NF-κB;p38 MAPK; CAS: 14216-03-6 | ||||||
ChemFaces | 12 days | China To: | 90 | 1 mg | 6 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire